151 related articles for article (PubMed ID: 27638863)
1. FACIN, a Double-Edged Sword of the Emerging Periodontal Pathogen Filifactor alocis: A Metabolic Enzyme Moonlighting as a Complement Inhibitor.
Jusko M; Miedziak B; Ermert D; Magda M; King BC; Bielecka E; Riesbeck K; Eick S; Potempa J; Blom AM
J Immunol; 2016 Oct; 197(8):3245-3259. PubMed ID: 27638863
[TBL] [Abstract][Full Text] [Related]
2. Characterization and immunostimulatory activity of extracellular vesicles from Filifactor alocis.
Kim HY; Lim Y; An SJ; Choi BK
Mol Oral Microbiol; 2020 Jan; 35(1):1-9. PubMed ID: 31675472
[TBL] [Abstract][Full Text] [Related]
3. Filifactor alocis--a new emerging periodontal pathogen.
Aruni AW; Mishra A; Dou Y; Chioma O; Hamilton BN; Fletcher HM
Microbes Infect; 2015 Jul; 17(7):517-30. PubMed ID: 25841800
[TBL] [Abstract][Full Text] [Related]
4. [Filifactor alocis and its role in the etiology of chronic periodontitis].
Balmasova IP; Tsarev VN; Arutyunov SD; Babayev EA
Stomatologiia (Mosk); 2020; 99(3):78-82. PubMed ID: 32608955
[TBL] [Abstract][Full Text] [Related]
5. Role of the Filifactor alocis Hypothetical Protein FA519 in Oxidative Stress Resistance.
Aja E; Mishra A; Dou Y; Fletcher HM
Microbiol Spectr; 2021 Dec; 9(3):e0121221. PubMed ID: 34756068
[TBL] [Abstract][Full Text] [Related]
6. The emerging oral pathogen, Filifactor alocis, extends the functional lifespan of human neutrophils.
Miralda I; Vashishta A; Rogers MN; Lamont RJ; Uriarte SM
Mol Microbiol; 2022 Jun; 117(6):1340-1351. PubMed ID: 35437843
[TBL] [Abstract][Full Text] [Related]
7. Whole Transcriptome Analysis Reveals That
Miralda I; Vashishta A; Rogers MN; Rouchka EC; Li X; Waigel S; Lamont RJ; Uriarte SM
Front Immunol; 2020; 11():497. PubMed ID: 32373107
[TBL] [Abstract][Full Text] [Related]
8. Virulence of Filifactor alocis lipoteichoic acid on human gingival fibroblast.
Yoo HJ; Lee SH
Arch Oral Biol; 2022 Mar; 135():105370. PubMed ID: 35149329
[TBL] [Abstract][Full Text] [Related]
9.
Aja E; Mangar M; Fletcher HM; Mishra A
J Dent Res; 2021 Jul; 100(8):790-797. PubMed ID: 33719654
[No Abstract] [Full Text] [Related]
10. Putative Periodontal Pathogens,
Vashishta A; Jimenez-Flores E; Klaes CK; Tian S; Miralda I; Lamont RJ; Uriarte SM
Pathogens; 2019 May; 8(2):. PubMed ID: 31052371
[TBL] [Abstract][Full Text] [Related]
11. Regulation of matrix metalloproteinase-1 by Filifactor alocis in human gingival and monocytic cells.
Nokhbehsaim M; Nogueira AVB; Damanaki A; Dalagiorgou G; Eick S; Adamopoulos C; Piperi C; Basdra EK; Papavassiliou AG; Deschner J
Clin Oral Investig; 2020 Jun; 24(6):1987-1995. PubMed ID: 31444694
[TBL] [Abstract][Full Text] [Related]
12. Filifactor alocis: The Newly Discovered Kid on the Block with Special Talents.
Aruni W; Chioma O; Fletcher HM
J Dent Res; 2014 Aug; 93(8):725-32. PubMed ID: 24898946
[TBL] [Abstract][Full Text] [Related]
13. Proteome variation among Filifactor alocis strains.
Aruni AW; Roy F; Sandberg L; Fletcher HM
Proteomics; 2012 Nov; 12(22):3343-64. PubMed ID: 23008013
[TBL] [Abstract][Full Text] [Related]
14. Tobacco smoke exacerbates Filifactor alocis pathogenicity.
Iskander MMZ; Lamont GJ; Tan J; Pisano M; Uriarte SM; Scott DA
J Clin Periodontol; 2023 Jan; 50(1):121-130. PubMed ID: 36122937
[TBL] [Abstract][Full Text] [Related]
15. Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis.
Kuo CF; Lin YS; Chuang WJ; Wu JJ; Tsao N
Infect Immun; 2008 Mar; 76(3):1163-9. PubMed ID: 18174338
[TBL] [Abstract][Full Text] [Related]
16. Filifactor alocis Promotes Neutrophil Degranulation and Chemotactic Activity.
Armstrong CL; Miralda I; Neff AC; Tian S; Vashishta A; Perez L; Le J; Lamont RJ; Uriarte SM
Infect Immun; 2016 Dec; 84(12):3423-3433. PubMed ID: 27647870
[TBL] [Abstract][Full Text] [Related]
17. The Varied Proportion of
Neelakandan A; Potluri R; Yadalam PK; Chakraborty P; Saravanan AV; Arunraj R
Contemp Clin Dent; 2021; 12(4):433-438. PubMed ID: 35068845
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles derived from the periodontal pathogen Filifactor alocis induce systemic bone loss through Toll-like receptor 2.
Kim HY; Song MK; Gho YS; Kim HH; Choi BK
J Extracell Vesicles; 2021 Oct; 10(12):e12157. PubMed ID: 34648247
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
Strunk RC; Giclas PC
J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706
[No Abstract] [Full Text] [Related]
20. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
